A recently published staffing model survey has brought new insights into oncology pharmacy operations across the country.

The Hematology/Oncology Pharmacy Association Practice Outcomes and Professional Benchmarking Committee (POPBC) Oncology Pharmacy Staffing Model Task Force developed a survey-based study in order to help provide an outline of oncology pharmacy staffing and operation practices. Distributed between September 2021 and January 2022, the survey collected baseline data and staffing metrics for oncology pharmacies - including facilities, inpatient and outpatient services, informatics/technology and more. The responses not only provided further insight into the unique oncology pharmacy operations and staffing models around the country, but also highlighted a need for staffing model benchmarking and metrics.

The full results are now published in the Journal of Oncology Pharmacy Practice.


Authors: Andrew Wechter, Anne M. McDonnell, Emily Zimdars, Leanne Sakamoto and Mark Hamm

Read the full article here

Pharmacist with technology
HOPA News Late Breaking News

Late-Breaking HOPA News: AI Integration in Pharmacy

Aracely Sosa, PharmD; Katelyn Toeniskoetter, PharmD, BCOP; and Pearl Abraham, PharmD, BCPS, BCOP, dive into the basics and beyond of AI integration in pharmacy.

Diffuse large B-cell lymphoma
HOPA News Late Breaking News

Late-Breaking HOPA News: The Emerging Use of Bispecific Antibodies with Chemotherapy in Diffuse Large B-Cell Lymphoma

Katelynn Granger, PharmD, BCOP, and Matthew Warrick, PharmD, BCPS, BCOP, dive into the emerging use of bispecific antibodies with chemotherapy in diffuse large B-cell lymphoma.

Woman diagnosing breast cancer
HOPA News Late Breaking News

Late-Breaking HOPA News: Fam-trastuzumab deruxtecan-nxki for HER2 Ultralow Metastatic Breast Cancer

The ability of fam-trastuzumab deruxtecan-nxki to treat breast cancer patients with HER2 IHC 0 with positive membrane staining up to IHC 3+ has changed the treatment paradigm for metastatic disease.